|
Abstract
Anticoagulation with direct
oral anticoagulants (DOAC)
is becoming increasingly more
prominent for stroke prevention
in patients with Atrial Fibrillation
(AF). Whereas a vitamin k
analogue like warfarin would
traditionally be used for
this; DOACs offer several
advantages over warfarin.
This
review article will provide
an overview of the current
evidence supporting the use
of DOACs for anticoagulation
in AF and how a primary care
clinician would go about choosing
which DOACs to choose and
considerations that need to
be taken before initiation
of the drug.
Keywords:
Direct Oral Anticoagulants,
atrial fibrillation, stroke,
primary care, anticoagulation,
warfarin
|
